SCHD ETF Daily Update, 3/9/2026

FomoAnxiety · 2026-03-09T12:25:37+00:00

The Schwab U.S. Dividend Equity ETF (SCHD) has experienced a 0.42% decline in pre-market trading and a 1.86% drop over the past week. However, it has gained 9.69% in 2025, with a moderate buy rating and positive forecasts based on its holdings.

FomoAnxiety

2026-03-09 12:25:37

Abstract generation in progress

The Schwab U.S. Dividend Equity ETF SCHD -0.42% ▼ , which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, was down 0.42% in pre-market trading on Monday.

Claim 70% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

Overall, SCHD has lost 1.86% over the past five days but gained 9.69% in 2025, supported by steady dividend income and its focus on mature companies with stable cash flows.

SCHD’s Price Forecasts and Holdings

According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of analyst ratings on its holdings, SCHD is a Moderate Buy. The Street’s average price target of $33.18 implies an upside of 6.57%.

Currently, SCHD’s five holdings with the highest upside potential are:

Insperity NSP +4.56% ▲
Kforce KFRC -0.33% ▼
Fidelity National Financial FNF -0.24% ▼
Amerisafe AMSF -0.92% ▼
Moelis MC -3.56% ▼

Meanwhile, its five holdings with the greatest downside potential are:

LyondellBasell LYB +1.87% ▲
APA Corp. APA +0.93% ▲
Valero Energy VLO -1.49% ▼
Murphy Oil MUR +0.82% ▲
CF Industries Holdings CF +4.51% ▲

Revealingly, SCHD ETF’s Smart Score is seven, implying that this ETF will likely perform in line with the market.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.